Similar articles

• [Controlled study of the effect of long-term administration of canrenoate potassium in cirrhotic ascites].

  Traina M, Vizzini GB. Traina M, et al. Minerva Med. 1986 Jan 28;77(3-4):87-91. Minerva Med. 1986. PMID: 3511409 Clinical Trial. Italian.
• [Effect of spironolactone and K-canrenoate in ascitic cirrhosis. Double-blind study].

  Tempini S, Bellati G, Ideo G. Tempini S, et al. Minerva Dietol Gastroenterol. 1984 Jul-Sep;30(3):255-61. Minerva Dietol Gastroenterol. 1984. PMID: 6504374 Italian. No abstract available.
• Spironolactone and canrenoate: different antialdosteronic diuretic agents.

  Gentilini P. Gentilini P. Hepatology. 1991 May;13(5):999-1000. Hepatology. 1991. PMID: 2030004 No abstract available.
• [New clinical application of spironolactone].

  Fukuchi S. Fukuchi S. Nihon Rinsho. 1974 Nov 10;32(11):3326-32. Nihon Rinsho. 1974. PMID: 4615183 Review. Japanese. No abstract available.
• [Hyperaldosteronism, spironolactone and liver cirrhosis].

  Sort P, Guevara M, Arroyo V. Sort P, et al. Gastroenterol Hepatol. 1997 Mar;20(3):151-9. Gastroenterol Hepatol. 1997. PMID: 9162537 Review. Spanish. No abstract available.